Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/39040| Title: | Ocrelizumab in patients with early-stage RRMS - results from the phase IIIb ENSEMBLE trial and the matched real-world NTD MS registry cohort | Authors: | Hartung, H. -P. Holmoy, T. Wuerfel, J. Heer, Y. Braune, S. Bergmann, A. Zuercher, M. Liu, C. Kuenzel, T. Moore, S. Vollmer, T. |
Issue Date: | 2022 | Publisher: | SAGE PUBLICATIONS LTD | Source: | Multiple Sclerosis Journal, 28 (S3) , p. 673 -674 | Document URI: | http://hdl.handle.net/1942/39040 | ISSN: | 1352-4585 | e-ISSN: | 1477-0970 | ISI #: | 000866540802365 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Ocrelizumab.pdf | Published version | 4.68 MB | Adobe PDF | View/Open |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.